Filing Details

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. __)

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d)

AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)

Under the Securities Exchange Act of 1934

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☐ Rule 13d-1(b)

 

☒ Rule 13d-1(c)

 

☐ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

CUSIP NO. N7716A151

 

CUSIP NO. N7716A151

 

*See Item 4.

** Based on 49,215,444 Common Shares outstanding as of October 24, 2017 (as reported by the Issuer in Exhibit 99.1 to its Report on Form 6-K filed with the SEC on October 26, 2017).

Item 1.

 

(a)	Name of Issuer: SAPIENS INTERNATIONAL CORPORATION N.V. (the “Issuer”).

 

(b)	Address of Issuer’s Principal Executive Offices: 26 Harukmim St., Holon, 5885800 Israel

 

Item 2.

 

 

(a)	Name of Person Filing: This Statement is filed by:

(1)

Clal Insurance Enterprises Holdings Ltd.

 

(2)

IDB Development Corporation Ltd.

 

The foregoing entities are collectively referred to as the “Reporting Persons” in this Statement.

 

(1)       Clal Insurance Enterprises Holdings Ltd., an Israeli public corporation (“Clal”) may be deemed to beneficially own the Common Shares reported in this Statement.  See Item 4.

(2)       IDB Development and the Trustee own shares of Clal that currently represent approximately 5.0% and 34.8%, respectively, of the outstanding shares of Clal. See the note in the beginning of this Item 2.

 

Clal Insurance Enterprises Holdings Ltd.  – 36 Raul Walenberg St., Tel Aviv 66180, Israel

IDB Development Corporation Ltd.  -  The Triangular Tower, 44th floor, 3 Azrieli Center, Tel Aviv 67023, Israel

 

(c)	Place of Organization:

Place of organization of all Reporting Persons, as the case may be, is Israel.

 

(d)	Title of Class of Securities:

 

Common Shares, par value € 0.01 per share (the “Common Shares”).

 

(e)	CUSIP Number:

 

N7716A151

 

Item 3.

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 

Not applicable.

 

Item 4.

Ownership

 

All of the 2,719,363 Common Shares reported in this Statement as beneficially owned by Clal are held for members of the public through, among others, provident funds and/or pension funds and/or insurance policies, which are managed by subsidiaries of Clal, which subsidiaries operate under independent management and make independent voting and investment decisions. Consequently, this Statement shall not be construed as an admission by the Reporting Persons that they are the beneficial owners of any of the Common Shares covered by this Statement. 

 

Except as set forth above, see items 5-11 of the cover page hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Persons, which are incorporated herein.